Viewing Study NCT00535028

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2026-02-28 @ 9:11 PM
Study NCT ID: NCT00535028
Status: COMPLETED
Last Update Posted: 2007-09-26
First Post: 2007-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
Sponsor: Aerovance, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Allergic Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None asthma View
None allergy View
None interleukin-4 View
None interleukin-13 View
None IL-4 View
None IL-13 View
None atopic View
None late asthmatic response View
None inflammation View